Mice received treatment with G100 alone (10 μg, IT, 3x/week, injected into tumor on one side only), α- OX40 Ab (clone OX86, 200 μg, IP, 1x/week), or the combination of G100 plus α-OX40 Ab. The gene discussed is TNFRSF4; the disease is neoplasm.